XML 50 R2.htm IDEA: XBRL DOCUMENT
v3.25.1

Pay vs Performance Disclosure - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
Pay vs Performance Disclosure |  |  |  |  |
Pay vs Performance Disclosure, Table | PAY VERSUS PERFORMANCE As required under the SEC pay versus performance rules adopted under the Dodd-Frank Act (“PvP Rules”), we are providing the following information about the relationship between “compensation actually paid” to our CEO (referred to below as our principal executive officer or PEO) and average “compensation actually paid” to our named executive officers (“NEOs”) and certain financial performance of the Company for the last five years, in each case, calculated in a manner consistent with PvP Rules. For further information concerning the Company’s variable pay-for-performance philosophy and how the Company’s aligns executive compensation with the Company’s performance, refer to “Compensation Discussion and Analysis.”
PAY VERSUS PERFORMANCE
Year (a) |  | Summary Compensation Table Total for PEO (b) |  | Compensation Actually Paid to PEO (1) (c) |  | Average Summary Compensation Table Total for Non-PEO NEOs (2) (d) |  | Average Compensation Actually paid to Non-PEO NEOs (1) (2) (e) |  | Value of Initial Fixed $100 Investment Based On: |  | Net Income ($ in millions) (4) (h) |  | Company- Selected Measure: Adjusted Diluted EPS (5) (i)
| Total Shareholder Return (f) |  | Peer Group Total Shareholder Return (3) (g)
2024 |  |  | $ | 12,253,425 |  |  |  | $ | 19,816,257 |  |  |  | $ | 2,448,044 |  |  |  | $ | 3,232,756 |  |  |  | $ | 158 |  |  |  | $ | 146 |  |  |  | $ | 585 |  |  |  | $ | 3.47 |
2023 |  |  | $ | 11,182,166 |  |  |  | $ | 24,015,899 |  |  |  | $ | 2,457,117 |  |  |  | $ | 4,099,117 |  |  |  | $ | 141 |  |  |  | $ | 126 |  |  |  | $ | 756 |  |  |  | $ | 3.17 |
2022 |  |  | $ | 8,375,361 |  |  |  | $ | (5,956,688 | ) (7) |  |  | $ | 1,673,157 |  |  |  | $ | (8,738 | ) (8) |  |  | $ | 119 |  |  |  | $ | 126 |  |  |  | $ | 414 |  |  |  | $ | 1.72 |
2021 |  |  | $ | 8,889,526 |  |  |  | $ | 26,421,358 |  |  |  | $ | 1,743,820 | (6) |  |  | $ | 3,270,073 | (6) |  |  | $ | 149 |  |  |  | $ | 133 |  |  |  | $ | 828 |  |  |  | $ | 3.04 |
2020 |  |  | $ | 9,902,703 |  |  |  | $ | 22,777,595 |  |  |  | $ | 2,018,372 |  |  |  | $ | 3,794,101 |  |  |  | $ | 125 |  |  |  | $ | 116 |  |  |  | $ | 786 |  |  |  | $ | 2.85 |
(1) | The dollar amounts reported in columns (c) and (e) represent the amount of “compensation actually paid” (“CAP”) to Mr. Farrell, and to our NEOs other than Mr. Farrell, respectively. The dollar amounts do not reflect the actual amount of compensation earned by or paid to our NEOs during the applicable year. In accordance with the PvP Rules, the following adjustments were made to the “Total” amount of compensation reported on the Summary Compensation Table (“SCT”):
PEO SCT Total to CAP Reconciliation |
Year |  | Salary |  |  | Bonus and Non-Equity Incentive Compensation |  |  | All Other Compensation (i) |  |  | SCT Total |  |  | Deductions from SCT Total (ii) |  |  | Additions to SCT Total (iii) |  |  | CAP |
2024 |  | $ | 1,231,633 |  |  | $ | 2,499,000 |  |  | $ | 462,792 |  |  | $ | 12,253,425 |  |  | $ | (8,060,000 | ) |  | $ | 15,622,831 |  |  | $ | 19,816,257 |
2023 |  | $ | 1,183,975 |  |  | $ | 2,530,700 |  |  | $ | 235,191 |  |  | $ | 11,182,166 |  |  | $ | (7,232,300 | ) |  | $ | 20,066,032 |  |  | $ | 24,015,899 |
2022 |  | $ | 1,156,275 |  |  | $ | 453,600 |  |  | $ | 174,764 |  |  | $ | 8,375,361 |  |  | $ | (6,590,722 | ) |  | $ | (7,741,328 | ) (7) |  | $ | (5,956,688 | ) (7)
2021 |  | $ | 1,117,400 |  |  | $ | 1,130,800 |  |  | $ | 281,718 |  |  | $ | 8,889,526 |  |  | $ | (6,359,608 | ) |  | $ | 23,891,440 |  |  | $ | 26,421,358 |
2020 |  | $ | 1,084,825 |  |  | $ | 2,195,700 |  |  | $ | 447,873 |  |  | $ | 9,902,703 |  |  | $ | (6,174,305 | ) |  | $ | 19,049,196 |  |  | $ | 22,777,595 |
Average Non-PEO NEOs (2) SCT Total to CAP Reconciliation |
Year |  | Salary |  |  | Bonus and Non-Equity Incentive Compensation |  |  | All Other Compensation (i) |  |  | SCT Total |  |  | Deductions from SCT Total (ii) |  |  | Additions to SCT Total (iii) |  |  | CAP |
2024 |  | $ | 448,076 |  |  | $ | 576,225 |  |  | $ | 113,938 |  |  | $ | 2,448,044 |  |  | $ | (1,309,806 | ) |  | $ | 2,094,517 |  |  | $ | 3,232,756 |
2023 |  | $ | 548,225 |  |  | $ | 662,375 |  |  | $ | 177,561 |  |  | $ | 2,457,117 |  |  | $ | (1,068,956 | ) |  | $ | 2,710,956 |  |  | $ | 4,099,117 |
2022 |  | $ | 533,613 |  |  | $ | 117,575 |  |  | $ | 84,254 |  |  | $ | 1,673,157 |  |  | $ | (937,716 | ) |  | $ | (744,180 | ) (8) |  | $ | (8,738 | ) (8)
2021 |  | $ | 513,474 |  |  | $ | 285,050 |  |  | $ | 107,146 |  |  | $ | 1,743,820 |  |  | $ | (838,150 | ) |  | $ | 2,364,402 |  |  | $ | 3,270,073 |
2020 |  | $ | 501,338 |  |  | $ | 565,600 |  |  | $ | 144,288 |  |  | $ | 2,018,372 |  |  | $ | (807,146 | ) |  | $ | 2,582,875 |  |  | $ | 3,794,101 |
| (i) | Reflects “all other compensation” reported in the SCT for each year shown.
| (ii) | Represents the grant date fair value of equity-based awards granted each year. We do not have a pension program for any of the years reflected in this table; therefore, a deduction from SCT total related to pension value is not needed.
| (iii) | Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP for fiscal year 2024 is further detailed in the supplemental table below:
PEO Equity Component of CAP for Each Fiscal Year (FY)
Year |  | Equity Type |  | Fair Value of Current Year Equity Awards at 12/31 (IV) (a) |  | Change in Value of Prior Years’ Awards That Vested in FY (IV) (b) |  | Change in Value of Prior Years’ Awards Unvested at 12/31 (IV) (c) |  | Equity Value Included in CAP (d) = (a) + (b) + (c)
2024 |  |  |  | Options/RSUs/PSUs |  |  |  | $ | 8,782,262 |  |  |  | $ | 3,246,832 |  |  |  | $ | 3,593,737 |  |  |  | $ | 15,622,831 |
2023 |  |  |  | Options/RSUs/PSUs |  |  |  | $ | 9,453,817 |  |  |  | $ | 5,228,516 |  |  |  | $ | 5,383,700 |  |  |  | $ | 20,066,032 |
2022 |  |  |  | Options |  |  |  | $ | 6,325,489 | (7) |  |  | $ | (4,379,219 | ) |  |  | $ | (9,687,598 | ) (7) |  |  | $ | (7,741,328 | ) (7)
2021 |  |  |  | Options |  |  |  | $ | 10,985,931 |  |  |  | $ | (1,173,880 | ) |  |  | $ | 14,079,390 |  |  |  | $ | 23,891,440 |
2020 |  |  |  | Options |  |  |  | $ | 7,482,445 |  |  |  | $ | 1,887,995 |  |  |  | $ | 9,678,757 |  |  |  | $ | 19,049,196 |
Average Non-PEO NEOs (2) Equity Component of CAP for each Fiscal Year (FY)
Year |  | Equity Type |  | Fair Value of Current Year Equity Awards at 12/31 (IV) (a) |  | Change in Value of Prior Years’ Awards That Vested in FY (IV) (b) |  | Change in Value of Prior Years’ Awards Unvested at 12/31 (IV) (c) |  | Equity Value Included in CAP (d) = (a) + (b) + (c)
2024 |  |  |  | Options/RSUs/PSUs |  |  |  | $ | 1,365,146 |  |  |  | $ | 314,071 |  |  |  | $ | 415,300 |  |  |  | $ | 2,094,517 |
2023 |  |  |  | Options/RSUs/PSUs |  |  |  | $ | 1,397,538 |  |  |  | $ | 578,670 |  |  |  | $ | 734,748 |  |  |  | $ | 2,710,956 |
2022 |  |  |  | Options |  |  |  | $ | 899,979 | (8) |  |  | $ | (494,713 | ) |  |  | $ | (1,149,445 | ) (8) |  |  | $ | (744,180 | ) (8)
2021 |  |  |  | Options |  |  |  | $ | 1,213,885 |  |  |  | $ | (145,752 | ) |  |  | $ | 1,296,270 |  |  |  | $ | 2,364,402 |
2020 |  |  |  | Options |  |  |  | $ | 978,154 |  |  |  | $ | 262,936 |  |  |  | $ | 1,341,785 |  |  |  | $ | 2,582,875 |
| (iv) | Stock option fair values, reported for CAP purposes, are estimated using a Black-Scholes option pricing model. The methodology used for determining the model inputs is consistent with the valuation performed on the grant date. This model requires several assumptions: (i.e., volatility, term, dividend yield, and risk-free interest rate) as of the measurement date.
|  | Restricted stock unit fair values are calculated using the stock price as of the measurement date.
Performance stock unit fair values, reported for CAP purposes, are estimated using a Monte Carlo pricing model. The methodology used for determining the model inputs is consistent with the valuation performed on the grant date. This model requires several assumptions: (i.e., volatility, financial metric multiplier, realized performance, and risk-free interest rate) as of the measurement date.
(2) | The non-principal executive officer (PEO) named executive officers (NEOs) reflected in columns (d) and (e) represent the following individuals for each of the years shown:
2024: Richard Dierker, Patrick de Maynadier, Carlos Ruiz Rabago, Michael Read 2023: Richard Dierker, Patrick de Maynadier, Barry Bruno, Carlos Linares 2022: Richard Dierker, Patrick de Maynadier, Barry Bruno, Carlos Linares 2021: Richard Dierker, Patrick de Maynadier, Britta Bomhard, Barry Bruno 2020: Richard Dierker, Patrick de Maynadier, Britta Bomhard, Steven Cugine
(3) | As permitted by SEC rules, the peer group referenced for purposes of “Peer Group Total Shareholder Return” is that of the S&P 500 Households Products Index, which is the industry index reported in Part II, Item 5, of our Annual Report on Form 10-K for the year ended December 31, 2024, in accordance with Item 201(e) of Regulation S-K. For the Company and our peer group, the TSR for each year reflects what the cumulative value would be based upon an initial $100 investment, including reinvestment of dividends, made at the beginning of the applicable performance period (January 1, 2020).
(4) | Net Income is as reported in our Form 10-K
(5) | Adjusted Diluted EPS, is as adjusted for purposes of calculating Adjusted Diluted EPS under the “Annual Incentive Plan” and includes the following:
2024: The impairment of intangible and other assets related to our Vitamin, Mineral and Supplement business ($1.10), the cost of restricted stock issued for the Hero acquisition ($0.08), and WaterPik tariff refunds (-$0.11), and for costs related to the Graphico acquisition ($0.03) 2023: The cost of restricted stock issued for the Hero acquisition ($0.12) 2022: The cost of restricted stock issued for the Hero acquisition ($0.03) and impact of the discontinuation of business in Russia due to the Russia/Ukraine war ($0.01) 2021: The favorable adjustment to Flawless earnout ($0.30) and the operational and transactional cost of the Therabreath acquisition ($0.02) 2020: The favorable adjustment to Flawless earnout ($0.28), gain on sale of an international brand ($0.01) and the operational and transactional cost of the Zicam acquisition ($0.02)
(6) | Compensation values disproportionately declined from the prior fiscal year due to the impact of the departure of Steven Cugine and Britta Bomhard, both longer tenured NEOs, and replacement with Barry Bruno
(7) | 2022: Compensation Actually Paid to PEO was modified to reflect an inadvertent inaccuracy in the December 31, 2022 valuation of outstanding stock options, which resulted in an understatement of $1,705,417
(8) | 2022: Compensation Actually Paid to Non-PEO NEOs was modified to reflect an inadvertent inaccuracy in the December 31, 2022 valuation of outstanding stock options, which resulted in an understatement of $240,367
Company Selected Measure Name | Adjusted Diluted EPS |  |  |  |
Named Executive Officers, Footnote |
(2) | The non-principal executive officer (PEO) named executive officers (NEOs) reflected in columns (d) and (e) represent the following individuals for each of the years shown:
2024: Richard Dierker, Patrick de Maynadier, Carlos Ruiz Rabago, Michael Read 2023: Richard Dierker, Patrick de Maynadier, Barry Bruno, Carlos Linares 2022: Richard Dierker, Patrick de Maynadier, Barry Bruno, Carlos Linares 2021: Richard Dierker, Patrick de Maynadier, Britta Bomhard, Barry Bruno 2020: Richard Dierker, Patrick de Maynadier, Britta Bomhard, Steven Cugine |  |  |  |
PEO Total Compensation Amount | $ 12,253,425 | $ 11,182,166 | $ 8,375,361 | $ 8,889,526 | $ 9,902,703
PEO Actually Paid Compensation Amount | $ 19,816,257 | 24,015,899 | (5,956,688) | 26,421,358 | 22,777,595
Adjustment To PEO Compensation, Footnote |
PEO SCT Total to CAP Reconciliation |
Year |  | Salary |  |  | Bonus and Non-Equity Incentive Compensation |  |  | All Other Compensation (i) |  |  | SCT Total |  |  | Deductions from SCT Total (ii) |  |  | Additions to SCT Total (iii) |  |  | CAP |
2024 |  | $ | 1,231,633 |  |  | $ | 2,499,000 |  |  | $ | 462,792 |  |  | $ | 12,253,425 |  |  | $ | (8,060,000 | ) |  | $ | 15,622,831 |  |  | $ | 19,816,257 |
2023 |  | $ | 1,183,975 |  |  | $ | 2,530,700 |  |  | $ | 235,191 |  |  | $ | 11,182,166 |  |  | $ | (7,232,300 | ) |  | $ | 20,066,032 |  |  | $ | 24,015,899 |
2022 |  | $ | 1,156,275 |  |  | $ | 453,600 |  |  | $ | 174,764 |  |  | $ | 8,375,361 |  |  | $ | (6,590,722 | ) |  | $ | (7,741,328 | ) (7) |  | $ | (5,956,688 | ) (7)
2021 |  | $ | 1,117,400 |  |  | $ | 1,130,800 |  |  | $ | 281,718 |  |  | $ | 8,889,526 |  |  | $ | (6,359,608 | ) |  | $ | 23,891,440 |  |  | $ | 26,421,358 |
2020 |  | $ | 1,084,825 |  |  | $ | 2,195,700 |  |  | $ | 447,873 |  |  | $ | 9,902,703 |  |  | $ | (6,174,305 | ) |  | $ | 19,049,196 |  |  | $ | 22,777,595 |
Non-PEO NEO Average Total Compensation Amount | $ 2,448,044 | 2,457,117 | 1,673,157 | 1,743,820 | 2,018,372
Non-PEO NEO Average Compensation Actually Paid Amount | $ 3,232,756 | 4,099,117 | (8,738) | 3,270,073 | 3,794,101
Adjustment to Non-PEO NEO Compensation Footnote |
Average Non-PEO NEOs (2) SCT Total to CAP Reconciliation |
Year |  | Salary |  |  | Bonus and Non-Equity Incentive Compensation |  |  | All Other Compensation (i) |  |  | SCT Total |  |  | Deductions from SCT Total (ii) |  |  | Additions to SCT Total (iii) |  |  | CAP |
2024 |  | $ | 448,076 |  |  | $ | 576,225 |  |  | $ | 113,938 |  |  | $ | 2,448,044 |  |  | $ | (1,309,806 | ) |  | $ | 2,094,517 |  |  | $ | 3,232,756 |
2023 |  | $ | 548,225 |  |  | $ | 662,375 |  |  | $ | 177,561 |  |  | $ | 2,457,117 |  |  | $ | (1,068,956 | ) |  | $ | 2,710,956 |  |  | $ | 4,099,117 |
2022 |  | $ | 533,613 |  |  | $ | 117,575 |  |  | $ | 84,254 |  |  | $ | 1,673,157 |  |  | $ | (937,716 | ) |  | $ | (744,180 | ) (8) |  | $ | (8,738 | ) (8)
2021 |  | $ | 513,474 |  |  | $ | 285,050 |  |  | $ | 107,146 |  |  | $ | 1,743,820 |  |  | $ | (838,150 | ) |  | $ | 2,364,402 |  |  | $ | 3,270,073 |
2020 |  | $ | 501,338 |  |  | $ | 565,600 |  |  | $ | 144,288 |  |  | $ | 2,018,372 |  |  | $ | (807,146 | ) |  | $ | 2,582,875 |  |  | $ | 3,794,101 |
Compensation Actually Paid vs. Total Shareholder Return |  |  |  |  |
Compensation Actually Paid vs. Net Income |  |  |  |  |
Compensation Actually Paid vs. Company Selected Measure |  |  |  |  |
Total Shareholder Return Vs Peer Group |  |  |  |  |
Tabular List, Table | Required Tabular Disclosure of Most Important Measures to Determine FY2024 CAP As described in greater detail in our Compensation Discussion and Analysis (“CD&A”) within the sections titled “2024 Key Business Highlights and Strong Pay for Performance Alignment” and “Annual Incentive Plan”, the Company’s executive compensation program reflects a variable pay-for-performance philosophy. The metrics that the Company uses for both our long-term and short-term incentive awards are selected based on an objective of incentivizing our NEOs to increase the value of our enterprise for our stockholders. The four items listed below represent the most important metrics we used to determine CAP for FY2024.
Most Important Performance Measures
>NetSales >RelativeGross Margin >AdjustedDiluted EPS >Cashfrom Operations
We believe in the importance of our stock price by delivering significant value to our stockholders and linking executive pay to our performance. Beyond the Company stock price, we believe that Adjusted Diluted EPS (which is a metric used for purposes of our Annual Incentive Plan – see additional details regarding adjustments in the section titled “Compensation Discussion and Analysis – Annual Incentive Plan”) represents the most important financial performance measure (that is not otherwise required to be disclosed in the above table) linking NEO CAP to Company performance because it is indicative of our profitability and impacts our stock price, and accordingly, Adjusted Diluted EPS is the “Company-Selected Measure” that is required to be disclosed in accordance with the PvP Rules. |  |  |  |
Total Shareholder Return Amount | $ 158 | 141 | 119 | 149 | 125
Peer Group Total Shareholder Return Amount | 146 | 126 | 126 | 133 | 116
Net Income (Loss) | $ 585,000,000 | $ 756,000,000 | $ 414,000,000 | $ 828,000,000 | $ 786,000,000
Company Selected Measure Amount | 3.47 | 3.17 | 1.72 | 3.04 | 2.85
PEO Name | Mr. Farrell |  |  |  |
Cost of Restricted Stock Issued (EPS) | $ (0.08) | $ (0.12) | $ (0.03) |  |
Favorable Adjustment to Flawless Earnout (EPS) |  |  |  | $ (0.3) | $ (0.28)
Gain on Sale of an International Brand (EPS) |  |  |  |  | $ (0.01)
Measure:: 1 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | NetSales |  |  |  |
Measure:: 2 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | RelativeGross Margin |  |  |  |
Measure:: 3 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | AdjustedDiluted EPS |  |  |  |
Measure:: 4 |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Name | Cashfrom Operations |  |  |  |
PEO | Equity Awards Adjustments |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ 15,622,831 | $ 20,066,032 | $ (7,741,328) | $ 23,891,440 | $ 19,049,196
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 8,782,262 | 9,453,817 | 6,325,489 | 10,985,931 | 7,482,445
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 3,246,832 | 5,228,516 | (4,379,219) | (1,173,880) | 1,887,995
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 3,593,737 | 5,383,700 | (9,687,598) | 14,079,390 | 9,678,757
PEO | All Other Compensation [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 462,792 | 235,191 | 174,764 | 281,718 | 447,873
PEO | Salary [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 1,231,633 | 1,183,975 | 1,156,275 | 1,117,400 | 1,084,825
PEO | Bonus and Non Equity Incentive Compensation [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 2,499,000 | 2,530,700 | 453,600 | 1,130,800 | 2,195,700
PEO | Deductions from SCT [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | (8,060,000) | (7,232,300) | (6,590,722) | (6,359,608) | (6,174,305)
PEO | Outstanding Stock Options [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  | 1,705,417 |  |
Non-PEO NEO | Equity Awards Adjustments |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 2,094,517 | 2,710,956 | (744,180) | 2,364,402 | 2,582,875
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 1,365,146 | 1,397,538 | 899,979 | 1,213,885 | 978,154
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 314,071 | 578,670 | (494,713) | (145,752) | 262,936
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 415,300 | 734,748 | (1,149,445) | 1,296,270 | 1,341,785
Non-PEO NEO | All Other Compensation [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 113,938 | 177,561 | 84,254 | 107,146 | 144,288
Non-PEO NEO | Salary [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 448,076 | 548,225 | 533,613 | 513,474 | 501,338
Non-PEO NEO | Bonus and Non Equity Incentive Compensation [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | 576,225 | 662,375 | 117,575 | 285,050 | 565,600
Non-PEO NEO | Deductions from SCT [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount | $ (1,309,806) | $ (1,068,956) | (937,716) | $ (838,150) | $ (807,146)
Non-PEO NEO | Outstanding Stock Options [Member] |  |  |  |  |
Pay vs Performance Disclosure |  |  |  |  |
Adjustment to Compensation, Amount |  |  | $ 240,367 |  |

X
- Definition Cost of restricted stock issued (EPS). + References No definition available. + Details
Name: | chd_CostofRestrictedStockIssuedEPS
Namespace Prefix: | chd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Favorable adjustment to flawless earnout (EPS). + References No definition available. + Details
Name: | chd_FavorableAdjustmenttoFlawlessEarnoutEPS
Namespace Prefix: | chd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gain on sale of an international brand (EPS). + References No definition available. + Details
Name: | chd_GainonSaleofanInternationalBrandEPS
Namespace Prefix: | chd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=4
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=chd_AllOtherCompensationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=chd_SalaryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=chd_BonusAndNonEquityIncentiveCompensationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=chd_DeductionsfromSCTMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=chd_OutstandingStockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |